Patents Assigned to LANNETT CO INC
  • Publication number: 20090148512
    Abstract: A method for reducing the resistance of an MRSA bacterium to an antibiotic selected from the group consisting of vancomycin and methicillin comprising administering to a patient in need thereof an effective amount of chloramphenicol or analogues thereof. The invention is also directed to chloramphenicol containing pharmaceutical compositions.
    Type: Application
    Filed: April 17, 2008
    Publication date: June 11, 2009
    Applicant: LANNETT CO INC
    Inventor: Arthur P. Bedrosian